Efficacy and safety profile of the potent and selective bradykinin B2 receptor antagonist icatibant in healthy volunteers

被引：0

|

作者：

Rosenkranz, B.

Brunner-Ferber, F.

Knolle, J.

机构：

[1] Jerini AG, Berlin, Germany

[2] Brunner Naga, Hlth Sci Consulting, Zurich, Switzerland

来源：

ALLERGY | 2007年 / 62卷

关键词：

D O I：

暂无

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

引用

收藏

页码：308 / 308

页数：1

相关论文

共 50 条

[1] Blocking the bradykinin response: Pharmacodynamics and safety of icatibant, a potent and selective bradykinin B2 receptor antagonist
Zimmermann, Jens
Rosenkranz, Bernd
Brunner-Ferber, Francoise
Knolle, Jochen
MOLECULAR IMMUNOLOGY, 2008, 45 (16) : 4157 - 4157
[2] Absolute bioavailability of subcutaneously administered icatibant, a selective and potent bradykinin B2 receptor antagonist
Wagner, F.
Rosenkranz, B.
Knolle, J.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2007, 119 (01) : S274 - S274
[3] The efficacy and safety of Icatibant, a selective bradykinin B2 receptor antagonist, for treating the symptoms of hereditary angioedema attacks
Cicardi, M.
ALLERGY, 2008, 63 : 474 - 474
[4] Icatibant, a potent and selective bradykinin B2 receptor antagonist, is effective in treating patients with Hereditary Angioedema (HAE)
Levy, R. J.
Goodman, S.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2007, 119 (01) : S277 - S277
[5] Repeated hereditary angioedema attacks can be effectively treated with the selective, potent bradykinin B2 receptor antagonist Icatibant
Aberer, W.
ALLERGY, 2008, 63 : 474 - 474
[6] Icatibant, a new bradykinin B2 receptor antagonist, for hereditary angioedema attacks
Reshef, A.
Liebovich, I.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2008, 121 (02) : S102 - S102
[7] Treatment of idiopathic nonhistaminergic angioedema with bradykinin B2 receptor antagonist icatibant
Del Corso, I.
Puxeddu, I.
Sardano, E.
Geraci, S.
Breggia, M.
Rocchi, V.
Migliorini, P.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2012, 108 (06) : 460 - 461
[8] Icatibant, the bradykinin B2 receptor antagonist with target to the interconnected kinin systems
Charignon, Delphine
Spaeth, Peter
Martin, Ludovic
Drouet, Christian
EXPERT OPINION ON PHARMACOTHERAPY, 2012, 13 (15) : 2233 - 2247
[9] Treatment of idiopathic angio-edema with Icatibant, a bradykinin B2 receptor antagonist
Bork, K.
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2009, 7 : 177 - 177
[10] Treatment for hereditary angioedema with the bradykinin (B2) receptor antagonist Icatibant (JE 049)
Rosenkranz, B
Meng, G
Knolle, J
Bork, K
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2006, 62 : 166 - 167

← 1 2 3 4 5 →